Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New serotonin reuptake inhibitors and 5-HT1A receptor antagonists discovered at Wyeth

Jan. 21, 2009

ReNeuron receives U.K. approval for ground-breaking clinical trial of ReN-001 in ischemic stroke

Jan. 20, 2009

Alzheimer's Drug Discovery Foundation provides grant to Edunn Biotechnology

Jan. 20, 2009

AstraZeneca imparts novel metabotropic glutamate receptor oxadiazole ligands

Jan. 20, 2009

Peptimmune grants Novartis exclusive option to license PI-2301 for MS

Jan. 19, 2009

Scientists at Janssen describe new analgesic FAAH inhibitors in recent patent

Jan. 19, 2009

Novel mgluR5 positive allosteric modulators developed at GSK for schizophrenia

Jan. 19, 2009

Analgesic calcium channel alpha2-delta subreceptor ligands claimed by Kyowa Hakko Kirin

Jan. 19, 2009

Copernicus and the University of Kentucky to collaborate on DNA therapy for PD

Jan. 19, 2009

Benefit seen with multi-herbal product Yi-Gan San in vascular dementia patients

Jan. 19, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...